These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1428467

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report.
    Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS.
    Drugs; 1976; 12(4):249-57. PubMed ID: 786608
    [Abstract] [Full Text] [Related]

  • 3. Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis.
    Kostarelos K, Teknetzis A, Lefaki I, Ioannides D, Minas A.
    J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):5-9. PubMed ID: 10877245
    [Abstract] [Full Text] [Related]

  • 4. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments.
    Stoughton RB.
    Int J Dermatol; 1992 Oct; 31 Suppl 1():26-8. PubMed ID: 1428464
    [Abstract] [Full Text] [Related]

  • 5. Betamethasone valerate foam for treatment of nonscalp psoriasis.
    Stein LF, Sherr A, Solodkina G, Gottlieb AB, Chaudhari U.
    J Cutan Med Surg; 2001 Oct; 5(4):303-7. PubMed ID: 11907840
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J, Brodthagen H.
    Dermatologica; 1976 Oct; 152 Suppl 1():209-14. PubMed ID: 782955
    [Abstract] [Full Text] [Related]

  • 7. Halomethasone (C 48.401-Ba) for the topical treatment of common dermatoses.
    de la Brassine M, Kint A, Lachapelle JM, Tennstedt D.
    J Int Med Res; 1984 Oct; 12(5):307-9. PubMed ID: 6238861
    [Abstract] [Full Text] [Related]

  • 8. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations.
    Gibson JR, Kirsch JM, Darley CR, Harvey SG, Burke CA, Hanson ME.
    Br J Dermatol; 1984 Jul; 111 Suppl 27():204-12. PubMed ID: 6378245
    [Abstract] [Full Text] [Related]

  • 9. The clinical assessment of topical corticosteroid activity.
    Wilson L.
    Br J Dermatol; 1976 Mar; 94 suppl 12():33-42. PubMed ID: 773412
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients.
    Andreassi L, Giannetti A, Milani M, Scale Investigators Group.
    Br J Dermatol; 2003 Jan; 148(1):134-8. PubMed ID: 12534607
    [Abstract] [Full Text] [Related]

  • 11. Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
    Woodford R.
    Arch Dermatol; 1986 Dec; 122(12):1355. PubMed ID: 3789765
    [No Abstract] [Full Text] [Related]

  • 12. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
    Seidenari S, Di Nardo A, Mantovani L, Giannetti A.
    Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
    [Abstract] [Full Text] [Related]

  • 13. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study.
    Ruzicka T, Lorenz B.
    Br J Dermatol; 1998 Feb; 138(2):254-8. PubMed ID: 9602870
    [Abstract] [Full Text] [Related]

  • 14. Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
    Bluefarb SM, Howard FM, Leibsohn E, Schlagel CA, Wexler L.
    J Int Med Res; 1976 Feb; 4(6):454-61. PubMed ID: 800385
    [Abstract] [Full Text] [Related]

  • 15. Comparison of topical treatment with desoxymethasone solution 0.25% with salicylic acid 1% and betamethasone valerate solution 0.1% in patients with psoriasis of the scalp.
    Hillström L.
    J Int Med Res; 1984 Feb; 12(3):170-3. PubMed ID: 6734919
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Halcinonide, a new topical anti-inflammatory steroid.
    Savin RC.
    J Int Med Res; 1976 Feb; 4(1):34-6. PubMed ID: 799976
    [Abstract] [Full Text] [Related]

  • 19. Human test models for bioequivalence of topical corticosteroids: a review.
    Olsen EA.
    Int J Dermatol; 1992 Oct; 31 Suppl 1():9-13. PubMed ID: 1428469
    [Abstract] [Full Text] [Related]

  • 20. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
    Smith EB, Gregory JF, Bartruff JK.
    South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.